Admedus : Appendix 3B - Placement

Name of entity

ADMEDUS LIMITED (Company)

ABN

35 088 221 078

1

+Class of +securities issued or to be issued

1. Ordinary fully paid shares (Shares).

2. Warrants convertible into Shares.

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

1. 760,000 Shares (subject to voluntary escrow arrangements) (Placement Shares).

2. 380,000 warrants, convertible into 380,000 Shares (subject to voluntary escrow arrangements)

3

Principal terms of the

+securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if

+convertible securities, the conversion price and dates for conversion)

1. Ordinary fully paid shares ranking equally with existing Shares.

2. Unquoted warrants convertible into 380,000 new Shares (presently unissued) at an exercise price of $0.79 each (Warrants).

The Placement Shares will be released from escrow 90 days after the date on which they were issued.

The Warrants expire on 23 December 2020.

The Warrants are transferable, subject to applicable laws and the holder assigning and novating the warrant agreement to the transferee.

The Warrants will be will be released from escrow 90 days after the date on which they were issued.

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please state:

• the date from which they do

• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

1. Yes, the Placement Shares rank equally with existing Shares.

2. No, the Warrants are a new class of unquoted security.

Warrants may be converted into new Shares in accordance with their terms and conditions. Upon conversion of the Warrants to Shares, the Shares issued will rank equally in all respects with quoted Shares.

5

Issue price or consideration

1. $0.66 per Placement Share amounting to an aggregate of $501,600

2. Nil monetary consideration.

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

The Placement Shares and the Warrants were issued for the purpose of a private placement to sophisticated/institutional investors.

Funds raised from the issue of the Shares will be used to support ongoing programs within the Company, including the progression of the HPV immunotherapy program into a clinical study in 2016 and continued expansion of the regenerative medicine product portfolio.

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

6b

The date the security holder resolution under rule 7.1A was passed

13 November 2015

6c

Number of +securities issued without security holder approval under rule 7.1

a. 760,000

b. 380,000

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

N/A

6f

Number of securities issued under an exception in rule 7.2

N/A

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

N/A

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Listing Rule 7.1 capacity: 10,815,382

Listing Rule 7.1A capacity: 18,495,667

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

1. 23 December 2015

2. 23 December 2015

Number

+Class

8

Number and +class of all

+securities quoted on ASX (including the securities in section 2 if applicable)

196,254,798

Ordinary Shares